The Extracellular RNA Communication Consortium has published 500+ research articles since its inception in 2013. Articles in the category “Biomarkers” are listed here in reverse chronological order. Each article is tagged by category; you can browse different categories using the drop-down menu at the top of the page or by clicking on the tags of multi-category articles.
Srinivasan S et al.
Charest A.
Meabon JS et al.
J Neurol Sci (2020) 417:117049.
Li F et al.
Cancers (Basel) (2020) 12:2041.
Yekula A et al.
Hao N et al.
Acoustofluidics-assisted engineering of multifunctional three-dimensional zinc oxide nanoarrays.
Tran AM et al.
Front Cell Dev Biol (2020) 8:50.
Yekula A et al.
From laboratory to clinic: Translation of extracellular vesicle based cancer biomarkers.
Rao SL et al.
Altered level of salivary placental growth factor is associated with preeclampsia.
Silverman MG et al.
Circulating miRNAs and risk of sudden death in patients with coronary heart disease.
JACC Clin Electrophysiol (2020) 6:70-79.
Wang Z et al.
Sun L et al.
Theranostics (2019) 9:8409-8425.
Lee MY et al.
Distinct profiles of cell-free microRNAs in plasma of veterans with Post-Traumatic Stress Disorder.
Kaczor-Urbanowicz KE et al.
Clinical validity of saliva and novel technology for cancer detection.
Biochim Biophys Acta Rev Cancer (2019) 1872:49-59.
Petrescu GED et al.
MicroRNA based theranostics for brain cancer: Basic principles.
J Exp Clin Cancer Res (2019) 38:231.
Lee MY et al.
A biological function based biomarker panel optimization process.
Ghai V et al.
Giraldez MD et al.
Gonzalez-Villasana V et al.
Dis Markers (2019) 2019:6852917.
Bach DH, Lee SK & Sood AK.
Mol Ther Nucleic Acids (2019) 16:118-129.
Dawes C & Wong DTW.
Role of saliva and salivary diagnostics in the advancement of oral health.
Ghai V et al.
Circulating RNAs as predictive markers for the progression of type 2 diabetes.
J Cell Mol Med (2019) 23:2753-2768.
Wiedrick JT et al.
Validation of microRNA biomarkers for Alzheimer’s Disease in human cerebrospinal fluid.
J Alzheimers Dis (2019) 67:875-891.
Pua HH et al.
Cell Rep (2019) 26:933-944.e4.
Varkaris A et al.
Br J Cancer (2019) 120:340-345.
Gulei D et al.
CRISPR-based RNA editing: Diagnostic applications and therapeutic options.
Expert Rev Mol Diagn (2019) 19:83-88.
Lusardi TA et al.
Analytics of Cerebrospinal Fluid microRNA quantitative PCR studies.
Mol Neurobiol (2019) 56:4988-4999.
Smith EMD et al.
Clin Immunol (2019) 198:71-78.
Bei Y et al.
Circular RNAs as potential theranostics in the cardiovascular system.
Mol Ther Nucleic Acids (2018) 13:407-418.
Hinger SA et al.
Cell Rep (2018) 25:715-725.e4.
Antoury L et al.
Narla V et al.
Unique circulating microRNA profiles in HIV infection.
J Acquir Immune Defic Syndr (2018) 79:644-650.
Regev K et al.
Identification of MS-specific serum miRNAs in an international multicenter study.
Neurol Neuroimmunol Neuroinflamm (2018) 5:e491.
Li F et al.
Clin Chem (2018) 64:1513-1521.
Shah RV et al.
Associations of circulating extracellular RNAs with myocardial remodeling and heart failure.
JAMA Cardiol (2018) 3:871-876.
Silva AM et al.
Profiling the circulating miRnome reveals a temporal regulation of the bone injury response.
Theranostics (2018) 8:3902-3917.
Ghai V et al.
Kidney Int Rep (2018) 3:555-572.
Danielson KM et al.
Plasma circulating extracellular RNAs in Left Ventricular Remodeling post-Myocardial Infarction.
EBioMedicine (2018) 32:172-181.
Kaczor-Urbanowicz KE et al.
Salivary exRNA biomarkers to detect gingivitis and monitor disease regression.
J Clin Periodontol (2018) 45:806-817.
Koupenova M et al.
Micro RNAs from DNA viruses are found widely in plasma in a large observational human population.
Fallen S et al.
J Cell Mol Med (2018) 22:2760-2773.
Nonaka T & Wong DTW.
Liquid biopsy in head and neck cancer: Promises and challenges.
Baecher-Allan C, Kaskow BJ & Weiner HL.
Multiple Sclerosis: Mechanisms and immunotherapy.
Raheja R et al.
Correlating serum microRNAs and clinical parameters in amyotrophic lateral sclerosis.
Muscle Nerve (2018) 58:261-269.
Shah R et al.
Circ Heart Fail (2018) 11:e004278.
Reategui E et al.
Bei Y et al.
Extracellular vesicles in cardiovascular theranostics.
Theranostics (2017) 7:4168-4182.
Related Pathway
Wei Z et al.
Coding and noncoding landscape of extracellular RNA released by human glioma stem cells.
Willinger CM et al.
Circ Cardiovasc Genet (2017) 10:5.
Shah R et al.
Am J Physiol Heart Circ Physiol (2017) 313:H1162-H1167.
Shankar GM et al.
Liquid biopsy for brain tumors.
Expert Rev Mol Diagn (2017) 17:943-947.
Jones A et al.
miRNA signatures of insulin resistance in obesity.
Zhang Y et al.
Salivary extracellular RNA biomarkers for insulin resistance detection in Hispanics.
Diabetes Res Clin Pract (2017) 132:85-94.
Jayaram H et al.
Invest Ophthalmol Vis Sci (2017) 58:2884-2890.
Fuentes-Mattei E et al.
Plasma viral miRNAs indicate a high prevalence of occult viral infections.
EBioMedicine (2017) 20:182-192.
Figueroa JM et al.
Neuro Oncol (2017) 19:1494-1502.
Klingenberg M et al.
Non-coding RNA in hepatocellular carcinoma: Mechanisms, biomarkers and therapeutic targets.
J Hepatol (2017) 67:603-618.
Related Pathways: 1, 2
Mick E et al.
Stroke and circulating extracellular RNAs.
He Y et al.
A systematic study of dysregulated microRNA in Type 2 Diabetes Mellitus.
Xiao J et al.
Circulating miR-30d predicts survival in patients with acute heart failure.
Cell Physiol Biochem (2017) 41:865-874.
Shah R et al.
Extracellular RNAs are associated with insulin resistance and metabolic phenotypes.
Diabetes Care (2017) 40:546-553.
McManus DD et al.
Messenger RNA and microRNA transcriptomic signatures of cardiometabolic risk factors.
Regev K et al.
JAMA Neurol (2017) 74:275-285.
Wang X, Kaczor-Urbanowicz KE & Wong DT.
Salivary biomarkers in cancer detection.
Matsuda A et al.
MicroRNAs as paracrine signaling mediators in cancers and metabolic diseases.
Best Pract Res Clin Endocrinol Metab (2016) 30:577-590.
Kaczor-Urbanowicz KE et al.
Saliva diagnostics – Current views and directions.
Exp Biol Med (Maywood) (2017) 242:459-472.
Dou Y et al.
Kaczor-Urbanowicz KE et al.
Emerging technologies for salivaomics in cancer detection.
J Cell Mol Med (2017) 21:640-647.
Lusardi TA et al.
MicroRNAs in human cerebrospinal fluid as biomarkers for Alzheimer’s disease.
J Alzheimers Dis (2017) 55:1223-1233.
Kanlikilicer P et al.
Ubiquitous release of exosomal tumor suppressor miR-6126 from ovarian cancer cells.
Cancer Res (2016) 76:7194-7207.
Regev K et al.
Comprehensive evaluation of serum microRNAs as biomarkers in Multiple Sclerosis.
Neurol Neuroimmunol Neuroinflamm (2016) 3:e267.
Smith EM et al.
Pediatr Nephrol (2017) 32:283-295.
Ghai V & Wang K.
Recent progress toward the use of circulating microRNAs as clinical biomarkers.
Arch Toxicol (2016) 90:2959-2978.
Yan IK et al.
Circulating extracellular RNA markers of liver regeneration.
Wu S et al.
Circulating microRNAs and life expectancy among identical twins.
Ann Hum Genet (2016) 80:247-56.
Van Roosbroeck K & Calin GA.
MicroRNAs in chronic lymphocytic leukemia: miRacle or miRage for prognosis and targeted therapies?
Byron SA et al.
Translating RNA sequencing into clinical diagnostics: Opportunities and challenges.
Nat Rev Genet (2016) 17:257-71. Related blog post
Rennert RC, Hochberg FH & Carter BS.
ExRNA in biofluids as biomarkers for brain tumors.
Cell Mol Neurobiol (2016) 36:353-60.
Sun Y et al.
Examining plasma microRNA markers for colorectal cancer at different stages.
Melman YF et al.
Circulation (2016) 133:e389-90.
Gleber-Netto FO et al.
Salivary biomarkers for detection of oral squamous cell carcinoma in a Taiwanese population.
Clin Cancer Res (2016) 22:3340-7.
Fabris L et al.
The potential of microRNAs as prostate cancer biomarkers.
Xu T et al.
Mohankumar S & Patel T.
Extracellular vesicle long noncoding RNA as potential biomarkers of liver cancer.
Brief Funct Genomics (2016) 15:249-56.
Monroig-Bosque Pdel C, Rivera CA & Calin GA.
MicroRNAs in cancer therapeutics: “From the bench to the bedside”.
Expert Opin Biol Ther (2015) 15:1381-5.
Laurent LC et al.
J Extracell Vesicles (2015) 4:26533.
Quinn JF et al.
Extracellular RNAs: Development as biomarkers of human disease.
J Extracell Vesicles (2015) 4:27495.
Ainsztein AM et al.
The NIH Extracellular RNA Communication Consortium.
J Extracell Vesicles (2015) 4:27493.
Lin X et al.
Noncoding RNAs in human saliva as potential disease biomarkers.
Melman YF et al.
Circulation (2015) 131:2202-16.
Akers JC et al.
miRNA contents of cerebrospinal fluid extracellular vesicles in glioblastoma patients.
J Neurooncol (2015) 123:205-16.
Majem B et al.
Non-coding RNAs in saliva: Emerging biomarkers for molecular diagnostics.
Int J Mol Sci (2015) 16:8676-98.
Saugstad JA.
Non-coding RNAs in stroke and neuroprotection.
Wong DT.
Salivary extracellular noncoding RNA: Emerging biomarkers for molecular diagnostics.
Ho GY et al.
Differential expression of circulating microRNAs according to severity of colorectal neoplasia.
Guzman N et al.
Mol Cancer Res (2015) 13:891-901.
Boukouris S & Mathivanan S.
Exosomes in bodily fluids are a highly stable resource of disease biomarkers.
Proteomics Clin Appl (2015) 9:358-67.
George J & Patel T.
Noncoding RNA as therapeutic targets for hepatocellular carcinoma.
Semin Liver Dis (2015) 35:63-74.
Srivastava A et al.
Exosomes: a role for naturally occurring nanovesicles in cancer growth, diagnosis and treatment.
Curr Gene Ther (2015) 15:182-92.
Fuentes L, Yakob M & Wong DT.
Emerging horizons of salivary diagnostics for periodontal disease.
Sato-Kuwabara Y et al.
Kawikova I & Askenase PW.
Diagnostic and therapeutic potentials of exosomes in CNS diseases.
Haga H & Patel T.
Molecular diagnosis of intrahepatic cholangiocarcinoma.
J Hepatobiliary Pancreat Sci (2015) 22:114-23.
Braicu C et al.
Exosomes as divine messengers: Are they the Hermes of modern molecular oncology?
Cell Death Differ (2015) 22:34-45.
Akat KM et al.
Proc Natl Acad Sci U S A (2014) 111:11151-6.
Yakob M et al.
Curr Oral Health Rep (2014) 1:133-141.
Redzic JS et al.
Extracellular RNA mediates and marks cancer progression.
Semin Cancer Biol (2014) 28:14-23.
Patel T.
Hochberg FH et al.
Glioma diagnostics and biomarkers: An ongoing challenge in the field of medicine and science.
Expert Rev Mol Diagn (2014) 14:439-52.
Ben-Dov IZ et al.
McManus DD et al.
Akers JC et al.
Lau C et al.
Role of pancreatic cancer-derived exosomes in salivary biomarker development.
J Biol Chem (2013) 288:26888-97.
Chen WW et al.
Mol Ther Nucleic Acids (2013) 2:e109.
Gonda DD et al.